Table 3. Validation of UC Santa Cruz Multiplex SARS-CoV-2 assay by a commercial lab using true positive and true negative asymptomatic surveillance samples.

Samples Tested Individually	Comparator Method Result
Candidate Test Result	Positive	Negative
Positive	29	0
Negative	1	30

(samples collected on asymptomatic patients).

Performance of the UCSC Multiplex SARS-CoV-2 Assay against the Pangea Comparator: Positive Percent Agreement: 29/30 = 97% (95%CI: 84%-100%), Negative Percent Agreement: 30/30 = 100% (95%CI: 90%-100%).